Trials / Completed
CompletedNCT01056237
Long-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus Nephritis
Research Institute of Nephrology, Jinling Hospital,
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 206 (actual)
- Sponsor
- Zhi-Hong Liu, M.D. · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
An multi-site, randomized, prospective study to compare the efficacy and safety of multi-target therapy as continuous induction and maintenance treatment versus CTX- Aza therapy.
Detailed description
Azathioprine (AZA) has been used for maintenance therapy of lupus nephritis for many years. We compare the efficacy and safety of multi-target therapy as continuous induction and maintenance treatment vs CTX-Aza.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Multi-target therapy | Tacrolimus (1-3mg/d) and mycophenolate mofetil(0.5-0.75g/d) |
| DRUG | Azathioprine | 1.0-2.0mg/kg/d |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2010-01-26
- Last updated
- 2015-07-31
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01056237. Inclusion in this directory is not an endorsement.